Prolonged Benefit from Ipilimumab Correlates with Improved Outcomes from Subsequent Pembrolizumab.Amanda Shreders,Richard Joseph,Chengwei Peng,Fei Ye,Shilin Zhao,Igor Puzanov,Jeffrey A. Sosman,Douglas B. JohnsonCancer Immunology Research（2016）引用 23|浏览23暂无评分关键词PD-1 and PD-L1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
